We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
A payment approach that has the potential to drive greater collaboration between all services within an urgent and emergency care network.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Find out how to kill trees on site using chemical treatments to prevent the spread of pests and diseases.
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
How to use a quasi-experimental study to evaluate your digital health product.
Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.
The Advisory Group on Military and Emergency Response Medicine (AGMERM) provides specialist advice to the Ministry of Defence on the medical aspects of defence against chemical, biological and radiological threats. AGMERM works with the Ministry of Defence .
Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions.
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
This document sets out the agreed way in which the Better Care Fund (BCF) will be implemented in the financial year 2022 to 2023.
Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.
Supporting health and care professionals to improve services by better understanding the health outcomes that some people in the Roma community face.
Information for British people on medical support in Thailand including mental health, lists of hospitals and care homes and how the British embassy can help.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
How to use a randomised controlled trial to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.